|
|
![]() |
|
|
|||||||||||||
|
May 4, 2006 N-Glycanase® Patent Maintained in Europe European Patent No. 0 472 651 in the name of Genzyme Corporation with opposition by Roche Diagnostics GmbH was maintained in oral proceedings before the Technical Board of Appeals. See here a copy of the preliminary minutes. See the full minutes. N-Glycanase® is a registered trademark of Genzyme Corporation, Boston, MA, USA. Recombinant PNGase F is covered by US Patent No 5,238,821 and EP Patent No 0472651 B1, which are exclusively licensed for manufacture by ProZyme, Inc.
|
|
|||||||||||
| products | ordering | support | news & events | about ProZyme | legal | site map | contact | search | |
|
© Copyright 2010-2013, ProZyme, Inc. |